Company Filing History:
1 out of 1,287 
1 out of 26 Years Active: 2011
Title: Innovations of Yoshitaka Kumakura in Tumor Diagnostics
Introduction
Yoshitaka Kumakura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of tumor diagnostics, particularly through his innovative work involving antibodies.
Latest Patents
Kumakura holds a patent for a tumor diagnostic agent used in PET, which comprises an anti-ROBO1 antibody. The objective of this invention is to provide a novel antibody capable of specifically recognizing ROBO1, which is expressed in cell membranes. This invention includes a hybridoma that produces the antibody, a method for its production, and the tumor diagnostic agent itself. The monoclonal antibody is designed to specifically recognize ROBO1 on the surface of cells, obtained by immunizing an animal with a ROBO1-displaying baculovirus.
Career Highlights
Throughout his career, Kumakura has worked with prestigious institutions, including The University of Tokyo and Perseus Proteomics Inc. His research has focused on advancing diagnostic techniques that can improve cancer detection and treatment.
Collaborations
Kumakura has collaborated with various professionals in his field, including Hiroko Iwanari, to enhance the development of his innovative solutions.
Conclusion
Yoshitaka Kumakura's work in developing a tumor diagnostic agent represents a significant advancement in medical technology. His contributions are poised to impact the future of cancer diagnostics positively.